BG85500A - Заместени n-(1-алкил-3-хидрокси-4-пиперидинил)бензамиди - Google Patents

Заместени n-(1-алкил-3-хидрокси-4-пиперидинил)бензамиди

Info

Publication number
BG85500A
BG85500A BG085500A BG8550088A BG85500A BG 85500 A BG85500 A BG 85500A BG 085500 A BG085500 A BG 085500A BG 8550088 A BG8550088 A BG 8550088A BG 85500 A BG85500 A BG 85500A
Authority
BG
Bulgaria
Prior art keywords
benzamides
piperidinyl
hydroxy
substituted
alkyl
Prior art date
Application number
BG085500A
Other languages
English (en)
Other versions
BG60560B1 (bg
Inventor
Georges Henri Paul Daele
Freddy Vlaeminck
Michel Anna Jozef Cleyn
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BG85500A publication Critical patent/BG85500A/bg
Publication of BG60560B1 publication Critical patent/BG60560B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретението се отнася до заместени n-(1-алкил-3-хидрокси-4-пиперидинил)бензамиди, техни n-оксидни форми, фармацевтично приемливите им кисели адитивни соли и стереохимично изомерни форми, а също така и до производство на състави, съдържащи тези съединения, и методи за лечение на топлокръвни животни. Със съединенията се стимулира подвижността на стомашно-чревния тракт при животни. 11 претенции
BG85500A 1987-09-25 1988-09-23 Заместени n-(1-алкил-3-хидрокси-4-пиперидинил)бензамиди BG60560B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10111587A 1987-09-25 1987-09-25

Publications (2)

Publication Number Publication Date
BG85500A true BG85500A (bg) 1993-12-24
BG60560B1 BG60560B1 (bg) 1995-08-28

Family

ID=22283104

Family Applications (1)

Application Number Title Priority Date Filing Date
BG85500A BG60560B1 (bg) 1987-09-25 1988-09-23 Заместени n-(1-алкил-3-хидрокси-4-пиперидинил)бензамиди

Country Status (24)

Country Link
EP (1) EP0309043B1 (bg)
JP (1) JP2830936B2 (bg)
KR (1) KR0124054B1 (bg)
CN (2) CN1021652C (bg)
AT (1) ATE113936T1 (bg)
AU (1) AU610241B2 (bg)
BG (1) BG60560B1 (bg)
CA (1) CA1317940C (bg)
DE (1) DE3852085T2 (bg)
DK (1) DK529888A (bg)
ES (1) ES2066781T3 (bg)
FI (1) FI94129C (bg)
GR (1) GR3014972T3 (bg)
HU (1) HU203724B (bg)
IE (1) IE64980B1 (bg)
IL (1) IL87847A0 (bg)
MA (1) MA21381A1 (bg)
NO (1) NO172580C (bg)
NZ (1) NZ226125A (bg)
PH (1) PH25504A (bg)
PT (1) PT88577B (bg)
SU (1) SU1625331A3 (bg)
TN (1) TNSN88096A1 (bg)
ZA (1) ZA887157B (bg)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
US5019583A (en) * 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
TW294595B (bg) * 1992-11-20 1997-01-01 Janssen Pharmaceutica Nv
JP3719612B2 (ja) * 1993-06-14 2005-11-24 塩野義製薬株式会社 ヘテロ環を含有する尿素誘導体
KR100388255B1 (ko) * 1994-09-27 2003-10-04 얀센 파마슈티카 엔.브이. 페닐-옥소-알킬-(4-피페리디닐)벤조에이트유도체
RU2154064C2 (ru) * 1994-09-27 2000-08-10 Жансен Фармасетика Н.В. N-замещенные пиперидинилбензоаты, их n-оксидные формы, фармацевтически приемлемые соли присоединения кислот и стереохимически изомерные формы, способы их получения, фармацевтическая композиция на их основе и промежуточный продукт
NZ330263A (en) * 1996-02-15 1999-06-29 Janssen Pharmaceutica Nv Esters of 3-hydroxy-piperidinemethanol derivatives to improve gastric emptying
US6096761A (en) * 1996-02-15 2000-08-01 Janssen Pharmaceutica N.V. Esters of 3-hydroxy-piperidinemethanol derivatives
TW402591B (en) 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
CN1076173C (zh) * 1998-05-29 2001-12-19 孙国文 香身茶剂
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
JP4584534B2 (ja) * 2000-06-07 2010-11-24 アリックス セラピューティクス 胃食道逆流性疾患の治療のための材料
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
US8138204B2 (en) 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
RU2374244C2 (ru) 2004-01-07 2009-11-27 Арикс Терапьютикс Стереоизомерные соединения и способы лечения желудочно-кишечных расстройств и расстройств центральной нервной системы
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
AU2006284601B2 (en) 2005-08-31 2012-12-20 Renexxion, Llc Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
WO2007149929A1 (en) * 2006-06-23 2007-12-27 Aryx Therapeutics, Inc. Piperidine derivatives for the treatment of gastrointestinal and cns disorders
KR100976063B1 (ko) * 2007-03-16 2010-08-17 동아제약주식회사 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법
US8343961B2 (en) 2009-03-31 2013-01-01 Arqule, Inc. Substituted heterocyclic compounds
MX2013002409A (es) * 2010-09-01 2013-04-03 Janssen Pharmaceutica Nv Antagonistas del receptor 5-ht2b.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
ZW12187A1 (en) * 1986-07-03 1989-02-01 Janssen Pharmaceutica Nv 4-(aroylamino)piperidinebutanamide derivatives
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals

Also Published As

Publication number Publication date
PH25504A (en) 1991-07-24
GR3014972T3 (en) 1995-05-31
NZ226125A (en) 1990-05-28
NO172580C (no) 1993-08-11
JPH01128968A (ja) 1989-05-22
AU610241B2 (en) 1991-05-16
IL87847A0 (en) 1989-03-31
FI94129C (fi) 1995-07-25
NO884208D0 (no) 1988-09-22
EP0309043A3 (en) 1990-08-08
PT88577A (pt) 1988-10-01
EP0309043A2 (en) 1989-03-29
FI94129B (fi) 1995-04-13
SU1625331A3 (ru) 1991-01-30
EP0309043B1 (en) 1994-11-09
CN1032438A (zh) 1989-04-19
PT88577B (pt) 1992-11-30
IE882889L (en) 1989-03-25
DK529888A (da) 1989-03-26
HUT48589A (en) 1989-06-28
ZA887157B (en) 1990-05-30
CN1021652C (zh) 1993-07-21
FI884375A7 (fi) 1989-03-26
AU2232288A (en) 1989-04-06
NO172580B (no) 1993-05-03
TNSN88096A1 (fr) 1990-07-10
KR890005053A (ko) 1989-05-11
MA21381A1 (fr) 1989-04-01
ES2066781T3 (es) 1995-03-16
CA1317940C (en) 1993-05-18
IE64980B1 (en) 1995-09-20
BG60560B1 (bg) 1995-08-28
ATE113936T1 (de) 1994-11-15
DE3852085T2 (de) 1995-04-06
JP2830936B2 (ja) 1998-12-02
NO884208L (no) 1989-03-28
KR0124054B1 (ko) 1997-11-27
FI884375A0 (fi) 1988-09-23
DK529888D0 (da) 1988-09-23
CN1067889A (zh) 1993-01-13
HU203724B (en) 1991-09-30
DE3852085D1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
BG85500A (bg) Заместени n-(1-алкил-3-хидрокси-4-пиперидинил)бензамиди
JO1613B1 (en) Derivatives of n - (3-hydroxy-4-piperidnil) dihydrobenzofuran, dihydro-2u-benzopyran or dihydro-benzodoxine) carboxymide
BG60698B2 (bg) Фармацевтични соли
NO1994011I1 (no) Cisaprid
NO890408L (no) 3-indolpyrodruesyre-derivater og deres farmasoeytiske anvendelse.
ATE38672T1 (de) 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen.
DK330786D0 (da) Anvendelse af n-(4-phenoxy-2,6-diisopropyl-phenyl)-n'-tert-butyl-thiourinstof til bekaempelse af hvide fluer
DK505983D0 (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmade til fremstilling deraf
ATE17737T1 (de) Pgrf von saeugetieren.
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
FI865220A0 (fi) Foerfarande foer framstaellning av sulfinyl- och sulfonylsubstituerade 3-benzazepiner.
SE8402199D0 (sv) Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten
BG31229A3 (bg) Метод за получаване на n-(5-тетразолил)-1-оксо-1н-6-алкоксипиримидо(1,2-а)- хинолин-2-карбоксамиди
BG31501A3 (bg) Метод за получаване на 3-арил-изоксазол-5-илбензоидна киселина и нейните соли
SU1161110A1 (ru) Способ лечени пептической звы двенадцатиперстной кишки
DE59005445D1 (de) Picolylselenobenzamide von Aminopyridinen, Anilinen und Picolylaminen.
JO1553B1 (en) New units N- (3- Hydroxy-4-Piperidinyl) benzamide
FR2636840B1 (fr) Sel du 6-piperidino-2,4-diaminopyrimidine-3-oxyde et de l'acide aceturique, leur preparation et leur application dermatocosmetologiques
RU93044977A (ru) Ароматические производные аминов и способ их получения
DE3790568T1 (de) Behandlung von kiefernmuskelstoerungen
RO82914B1 (ro) Sare dubla de magneziu si procedeu de preparare a sa
ATE103491T1 (de) Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5hydroxytryptophan.